tiprankstipranks
Crispr Therapeutics call volume above normal and directionally bullish
PremiumThe FlyCrispr Therapeutics call volume above normal and directionally bullish
28d ago
Crispr Therapeutics presents data on CTX112 at ASH Meeting
Premium
The Fly
Crispr Therapeutics presents data on CTX112 at ASH Meeting
1M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
Cathie Wood’s ARK Investment bought 409.5K shares of Crispr Therapeutics today
PremiumThe FlyCathie Wood’s ARK Investment bought 409.5K shares of Crispr Therapeutics today
2M ago
Crispr Therapeutics price target lowered to $53 from $59 at Stifel
Premium
The Fly
Crispr Therapeutics price target lowered to $53 from $59 at Stifel
2M ago
Crispr Therapeutics price target lowered to $55 from $59 at Barclays
Premium
The Fly
Crispr Therapeutics price target lowered to $55 from $59 at Barclays
2M ago
Cathie Wood Trims Tesla Stake, Shifts Focus to This Lesser-Known Stock
PremiumMarket NewsCathie Wood Trims Tesla Stake, Shifts Focus to This Lesser-Known Stock
3M ago
Cathie Wood’s ARK Investment bought 47.8K shares of Crispr Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment bought 47.8K shares of Crispr Therapeutics today
3M ago
Cathie Wood’s ARK Investment bought 34K shares of Crispr Therapeutics today
Premium
The Fly
Cathie Wood’s ARK Investment bought 34K shares of Crispr Therapeutics today
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100